Effects of monosodium glutamate administration in the neonatal period on the diabetic syndrome in KK mice.
Administration of monosodium glutamate (MSG) to KK mice during the neonatal period resulted in a syndrome of obesity, stunting and hypogonadism. In some animals the genetic predisposition to diabetes was unmasked with the development of marked hyperglycaemia and or hyperinsulinaemia. Food intake was not increased compared to controls. The elevated plasma glucose and insulin in fed MSG treated mice fell rapidly with food deprivation. Glucose disposal was comparable in MSG treated and control mice after IP glucose, but after oral glucose MSG treated mice showed impaired glucose tolerance. Insulin secretion was defective in MSG treated mice after IP but not after oral glucose.
D000284:Administration, Oral; D000818:Animals; D000831:Animals, Newborn; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000378:metabolism; D005215:Fasting; D005947:Glucose / Q000008:administration & dosage; D005971:Glutamates / Q000494:pharmacology*; D007031:Hypothalamus / Q000187:drug effects; D007274:Injections, Intraperitoneal; D007328:Insulin / Q000097:blood; D051379:Mice; D008820:Mice, Obese; D012970:Sodium Glutamate / Q000494:pharmacology*
D001786:Blood Glucose; D005971:Glutamates; D007328:Insulin; D005947:Glucose; D012970:Sodium Glutamate